Uncategorized
A Message About COVID-19
(This article was written on April 18, 2020. Numbers and statistics have changed.) Dear Clients and Friends: Thank you, your employees, families, and business associates
April 20, 2020
Providing a range of business valuation services for corporations, partnerships, professional practices, estates, judicial bodies, and individuals.
Our mission is to connect you with seasoned and reliable business valuation experts who are experts in the key events you encounter while running your business.
Establishing fair market value helps Sellers attract the right Buyers.
Determining the value of a business helps Buyers make smart offers.
A business appraisal helps owners and advisors navigate difficult times.
Determine tangible asset values with experts that know equipment.
A business appraisal helps bring fair and equitable asset distribution.
Determining fair market value brings clarity to an owner’s estate transfer.
Van Amburgh Valuation Associates deliver superior services backed by industry expertise, ensuring excellence and satisfaction in every aspect of our work.
Van Amburgh Valuation Associates, Inc. has performed more than 3,000 business valuations since its formation.
We offer analysis and data to help you create your business plan, SBA loan documentation, industry analysis, and more!
Has your business suffered from legal actions? We can help with a broad range of litigation support, including eminent domain and shareholder disputes.
Does your business need to make a major transaction? We can help with mergers, liquidation, appraisals, and much more!
Get our tips and perspective as you look to determine the value of your business.
(This article was written on April 18, 2020. Numbers and statistics have changed.) Dear Clients and Friends: Thank you, your employees, families, and business associates
When I was in the second grade, a car struck me and sent me flying 117 feet in the air. The survival from this accident
Article: Merck climbs after announcing massive growth for its top cancer drug, which is now on pace to generate $10 billion a year (MRK) Working